Home Business Nasdaq Halts KaloBios Pharmaceuticals, Inc.

Nasdaq Halts KaloBios Pharmaceuticals, Inc.

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.


NEW YORK, Dec. 17, 2015 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq:NDAQ) announced that trading was halted today in KaloBios Pharmaceuticals, Inc. (Nasdaq:KBIO) at 06:48:07 Eastern Time for “additional information requested” from the company at a last price of $23.59.

Trading will remain halted until KaloBios Pharmaceuticals, Inc. has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

 

NDAQO

 

 

CONTACT: Nasdaq Media Contact:
Peter Gau
+1.212.231.5475
[email protected]

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

GlobeNewswire
Editor

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.